Sean McCutcheon
Stock Analyst at Raymond James
(2.40)
# 2,381
Out of 5,154 analysts
12
Total ratings
33.33%
Success rate
8.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $10.42 | +130.33% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $98.40 | -22.76% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $9.55 | +25.65% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $13.84 | +369.65% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $5.51 | +63.34% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.15 | +411.63% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $8.68 | +164.98% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $11.32 | +253.36% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $60.41 | +15.87% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $18.97 | +353.35% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $10.42
Upside: +130.33%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $98.40
Upside: -22.76%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.55
Upside: +25.65%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $13.84
Upside: +369.65%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $5.51
Upside: +63.34%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.15
Upside: +411.63%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $8.68
Upside: +164.98%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $11.32
Upside: +253.36%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $60.41
Upside: +15.87%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $18.97
Upside: +353.35%